(株)カイオム・バイオサイエンスの貸借残高情報

主市場	業種	証券コード/EDINET	英名称
東証GRT	医薬品	4583/E26096	Chiome Bioscience Inc.

公表日	公表	貸付残高	前週比	新規貸付成約高	前週比	借入残高	前週比	新規借入成約高	前週比
2026/04/10	日証協	12,193,386株	+0.16%	2,491,332株	+35.46%	14,633,842株	-0.08%	217,560株	-14.85%
2026/04/03	日証協	12,174,386株	-1.14%	1,839,228株	-54.38%	14,645,059株	-0.47%	255,513株	-59.28%
2026/03/27	日証協	12,315,258株	+2.69%	4,031,316株	+134.65%	14,713,550株	+1.70%	627,502株	-3.93%
2026/03/19	日証協	11,992,274株	+3.75%	1,717,984株	-42.97%	14,466,934株	+2.90%	653,185株	+45.18%
2026/03/13	日証協	11,558,726株	-13.60%	3,012,582株	-42.66%	14,059,349株	-6.16%	449,918株	-69.21%
2026/03/06	日証協	13,378,658株	+20.88%	5,253,584株	+64.39%	14,982,067株	+9.44%	1,461,148株	+132.43%
2026/02/27	日証協	11,068,042株	+0.29%	3,195,784株	+18.36%	13,689,567株	+0.68%	628,649株	+2.30%
2026/02/20	日証協	11,035,758株	+4.28%	2,700,000株	-18.38%	13,596,666株	+2.01%	614,501株	-6.28%
2026/02/13	日証協	10,582,610株	-4.98%	3,307,896株	+172.95%	13,328,665株	-2.81%	655,698株	+74.71%
2026/02/06	日証協	11,137,710株	-0.20%	1,211,900株	-50.19%	13,713,763株	+0.29%	375,308株	-22.55%
2026/01/30	日証協	11,160,310株	+4.75%	2,433,000株	+1.06%	13,674,061株	+2.20%	484,551株	-20.74%
2026/01/23	日証協	10,653,910株	-0.57%	2,407,432株	+8.58%	13,379,158株	+0.50%	611,350株	-5.47%
2026/01/16	日証協	10,715,158株	+5.24%	2,217,268株	+97.35%	13,312,355株	+3.59%	646,751株	+20.19%
2026/01/09	日証協	10,181,542株	-7.40%	1,123,532株	-21.68%	12,851,050株	+11.98%	538,106株	-73.23%
2025/12/30	日証協	10,995,006株	+6.57%	1,434,616株	-30.95%	11,475,694株	-9.33%	2,009,901株	+552.99%
2025/12/26	日証協	10,317,174株	-5.27%	2,077,536株	-34.82%	12,656,394株	-2.19%	307,800株	-75.28%
2025/12/19	日証協	10,891,574株	+4.70%	3,187,488株	+137.85%	12,939,695株	+2.90%	1,245,288株	+210.70%
2025/12/12	日証協	10,402,990株	+0.24%	1,340,100株	-65.78%	12,574,695株	-0.50%	400,807株	-74.52%
2025/12/05	日証協	10,378,206株	+12.43%	3,916,700株	+202.53%	12,637,395株	+6.83%	1,572,800株	+194.75%

※株式分割は考慮していませんのでご注意ください。